Jhunne Galimba
Family · Kansas City, KSNPI 1740603935
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 344 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,705 and has fallen 56.7% since, to $739 in 2025. Among family clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 344 payments — averaging $17.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- Boehringer Ingelheim$618
- Johnson & Johnson$509
- Amgen$488
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$468
- Sanofi-aventis U.S. LLC$446
- plus $2K from 21 others
What the payments were for
- Food & beverage$5,997100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 85 | $1,068 |
| Boehringer Ingelheim | 41 | $618 |
| Johnson & Johnson | 28 | $509 |
| Amgen | 29 | $488 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $468 |
| Sanofi-aventis U.S. LLC | 26 | $446 |
| Bayer | 21 | $429 |
| Merck | 22 | $377 |
| AstraZeneca | 16 | $287 |
| Boston Scientific | 14 | $245 |
| Actelion Pharmaceuticals US, Inc. | 12 | $215 |
| Kestra Medical Technology Services, Inc. | 8 | $192 |
| Kowa Pharmaceuticals America, Inc. | 6 | $96 |
| Kiniksa Pharmaceuticals, Ltd. | 4 | $94 |
| Abbott | 3 | $91 |
| Pfizer | 4 | $68 |
| Novo Nordisk | 3 | $62 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $51 |
| Cvrx, Inc. | 2 | $32 |
| Esperion Therapeutics, Inc. | 2 | $31 |
| Tactile Systems Technology Inc | 1 | $22 |
| Sanofi | 1 | $22 |
| Edwards Lifesciences | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| GSK | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $14 |
| Amryt Pharma Holdings Ltd | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LifeVest$203
How this compares
$5,997 in reported general payments places this provider in the 95th percentile of 1,579 family providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 13 | $104 |
| ClopidogrelClopidogrel Bisulfate | 11 | $68 |
| Atorvastatin Calcium | 11 | $44 |
Paid to pharmacies, not to this prescriber.
Other family in Kansas City
- Zohra HussainiKansas City$329K
- Adam CaseKansas City$34K
- Kristina DelaneyKansas City$27K
- Amanda WilliamsKansas City$20K
- Mindy EldridgeKansas City$12K
- Liza RodriguezKansas City$11K
- Graceann SandriKansas City$6K
- Jennifer ChesterOverland Park$327K
- Amanda CaldwellLeawood$203K
- Kayla del RioWichita$147K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.